 ÏÊ»¨( 219)  ¼¦µ°( 0)
|
& f8 z8 ]- D0 O9 M
, r0 }4 s- V$ k; J) |9 k n9 d
/ J6 b7 j1 ?! m/ z9 C0 E) c´ó¼ÒºÃ£¬2 P% L$ U5 ~& I* J3 m% Y( }; o% y
4 A% z+ b2 \7 w" U2 ~»¶Ó¹âÁÙ½¡¿µÓªÑøÕ¾É̳ǡ£ÎÒÊǽ¡¿µÓªÑøÕ¾µÄ°æÖ÷¡£ÎÒ±ÏÒµÓÚU Of A ÓªÑøÏµ¡£Ä¿Ç°¾ÓªÓªÑø²úÆ·¡£ÎÒËù¾ÓªµÄÓªÑø²úÆ·±£Öʱ£Á¿¡£¶øÇÒÔÚͬÑùµÄÆ·ÅÆÀÎÒ±£Ö¤¼ÛÇ®×îµÍ¡£ ¿µ¼ÓÃÀ²úÆ·ÊÇÎÒĿǰ¾ÓªµÄÖ÷Òª²úÆ·Ö®Ò»¡£ÎªÁËÄúµÄ·½±ã£¬ËùÓвúÆ·µÄÏêϸÇé¿öºÍ¼ÛÇ®¿ÉÒÔµã»÷ÕâÀïÕÒµ½ - l( r) z6 b& Y' l% |5 s; d
[url]http://www.edmontonchina.ca/forumdisplay.php?fid=91
' }' M2 d/ V- h: |; o$ N4 `, O! T4 Q# P& H( n# e4 V6 U/ K- C" L
¶©¹º×Éѯ£º£¨780£©669-6586²úÆ·  780-249-1365
# ?' i6 L$ x! d; P% oEmail£º c.health@hotmail.com j# t# v; u! ?5 C
# d" X- j. l$ N$ Y# U1 k
¿µ¼ÓÃÀ²úÆ·¼ò½é£º
8 Q( d7 I, _! ^6 J7 `
3 ~2 \% Z5 ~4 i8 _+ d9 E" i¼ÓÃÀ¿ÆÑÐÖÆÒ©ÓÐÏÞ¹«Ë¾Î»ì¶×ÔÈ»×ÊÔ´·á¸»µÄ¼ÓÄô󰲴óÂÔÊ¡£¬Ç±ÐÄÑÐÖÆÌìȻҩÁƽ¡¿µ®bÆ·¡£ÎÒÃǵÄ×î´óÐÄÔ¸Êǽ«ÓÅÖÊÌìȻֲÎï»òº£ÑóÉúÎᆱ»ª£¬½áºÏ×ÔÈ»Éú»îµÄ½¡¿µÀíÄîÍÆ½é¸øËùÓмÒÍ¥£¬ ÁîÄãºÍ¼ÒÈËÊܵ½´¿×ÔÈ»µÄ±£»¤£¬×à³öÇáËɽ¡¿µÔÏÀÖ¡£ ) Y: f% b# x, E- t6 V' N
! \$ s4 h6 u6 \: n5 y
¼ÓÃÀ¿ÆÑÐÖÆÒ©ÊǼÓÄôó±¾ÍÁ¾ß¹æÄ£ºÍʵÁ¦µÄÖÆÒ©¹«Ë¾¡£ÎÒÃǵÄÖ÷ÒªÒµÎñ°üÀ¨ÓÅÖʱ£½¡Æ·µÄÉú®b¡¢ÁãÊÛ¡¢Åú·¢£¬¸ü ‘´Óʸ߼¶±£½¡Æ·Éú®bµÄ³§¼ÒºÍ¸öÈËÌṩ¿É¿¿ÖÜÈ«µÄ¼Ó¹¤·þÎñ (OEM)¡£×Ô³ÉÁ¢ÒÁʼ£¬¼ÓÃÀ¿ÆÑÐ ²»¶ÏͶ·Å´óÁ¿×ÊÔ´Ñо¿ÌìÈ»½¡¿µÆ·¡£Ê®¶àÄêǰÒѳɹ¦½«ÌìÈ»º£±ªÓÍ¡¢ÉÈýÎÄÓãÓÍÔÓÍת»¯Îª¶àÖÖ±£½¡¹¦Ð§£¬ÈÝÒ×ÎüÊյĽ¡¿µ®bÆ·¡£ÆäUNCLE BILL Æ·ÅÆµÄÌìÈ»º£±ªÓÍ£¬ÉÓãÓÍ£¬ÂÑÁ×Ö¬µÈÌìÈ»®bÆ·Ê®¶àÄêÀ´Ò»Ö±±¸ÊÜÏû·ÑÕßÐÅÀµ£¬ÊÇ´ó¼Ò×ÔÓúÍÀ¡ÔùÇ×ÓѵÄÊ×Ñ¡ºÍÖ¸¶¨®bÆ·¡£
" x' {$ h+ t& @- T1 `
4 G2 G8 d7 ]2 P0 q¶þÊ®ÔØ ¾Óª£¬ ¶þÊ®ÔØ³ÏÐÅ£¬ Ò»Èç¼ÈÍù. ¸ß¿Æ¼¼Í¶ÈëºÍ³¤¾QͶ×ʳɾÍÁ˼ÓÃÀ¿ÆÑÐÖÆÒ© ÔÚ½¡¿µ®bÆ·Òµ½çµÄÇ̳þµØÎ»£¬ÊµÁ¦²»ÈÝÖÃÒÉ¡£Ê±ÖÁ½ñÈÕ, ¼ÓÃÀ¿ÆÑÐÒÑ·¢Õ¹ ‘Ò»¼äÓÐʵÁ¦ºÍ¹æÄ£µÄÖÆÒ©¹«Ë¾¡£¼ÓÃÀµÄ¼¼ÊõÍÅÒ²ÈÕÒæ×³´ó£¬³ýÍøÂÞ±¾µØÒ½Ò©Ïµ¾«Ó¢Í⣬¸üÖØ½ðͶ×ÊÉ豸¾«Á¼µÄÒ©Æ·¼ìÑéʵÑéÊÒ£¬ ¶ÔÿÅú®bÆ·½øÐÐ Standard Operation Procedure (SOP)¼ì²â£¬½¨Á¢ÖÊÁ¿×·×Ù»ØÊÕϵͳ£¬ ¾ø¶Ô·ûºÏ¼ÓÄôóÎÀÉú²¿Ò©Îï¼à¹ÜÒªÇó, Æ·ÖÊ ‘Òµ½çÖ®¹Ú¡£ 2 K }/ w6 v( E0 D: V
8 z. H% Z$ Q$ J¼ÓÃÀ¿ÆÑÐÖÆÒ©´´Á¢ºÇ»¤ÉíÐĵġ°¿µ¼ÓÃÀ¡±£¬¡°±êÊ塱һϵÁб£½¡¾«Æ·£¬ ÁÆÐ§ÏÔÖø£¬ÉîÊÜÓüÒÐÅÀµ¡£¼ÓÃÀ¿ÆÑÐÊôÏÂËùÓЮbÆ·¾ùÒÑÉ걨¼ÓÄôóÎÀÉú²¿£¬ÊÇ×îÖµµÃÐÅÀµµÄÌìÈ»±£½¡Æ·Éú®b³§¼Ò¡¢ÖøÃû½¡¿µ®bÆ·¶À¼Ò´úÀíºÍÅú·¢ÉÌ¡£
/ r) }# G1 D$ C/ @# v* |: f
y8 `6 X: F! @9 I* M' [+ N6 L¼ÓÃÀ¿ÆÑÐÉèÓжàÌõÏȽøµÄÉú®bÏߣ¬´ÓÖÆÔìµ½°ü×°¸÷ÖÖÉú®b³ÌÐò£¬¾ùÓɵçÄÔ¿ØÖÆ£¬²¢ÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬¶ÔËùÓвÄÖʼ°ÖÆ³ÉÆ·½øÐÐÑϸñ²âÊÔ£¬·¢»Ó¿ÆÑ§¹ÜÀíµÄ³¬×¿Ð§ÄÜ¡£¼ÓÃÀµÄרҵÍŶӼá³ÖÒÔÆ·ÖÊΪ±¾£¬Á¦ÕéÍêÃÀ£¬²»¶ÏÇó½øºÍ´´Ð¡£
( [/ r2 y _" r& j( s$ \% x7 H
6 O; I( @! }4 z) N- x2 v1 D2 {¼ÓÃÀ¿ÆÑÐÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬ ÎÒÃǵÄרҵ¼¼ÊõÔ±¶Ô¸÷ÖÖÔÁϺÍÖÆ³ÉÆ·½øÐзÖÎö£¬ È·±£ÔÁϸßЧÐÔ£¬²¢Ñϸñ²âÊÔÿÅú²úÆ·µÄÖÊÁ¿ºÍ°²È«ÐÔ¡£¼ÓÃÀ¿ÆÑÐÖÆÒ©Ëù²ÉÓÃÔ²ÄÁÏ£¬ ÖÆÔì¹ý³ÌºÍ³ÉÖÊÁ¿¾ù·ûºÏ«ÃÀ¹úÒ©µä» * (US Pharmacopoeia (USP))±ê×¼£¬²¿·ÖÔÁϺͮbÆ·ÉõÖÁ³¬¹ý´Ë±ê×¼¡£ z0 a, e H% P7 l% z1 I
& v* ?+ A T0 y5 F: I¼ÓÃÀ¿ÆÑÐÖÆÒ©µÄרҵ¾«Ó¢ÓÐÀ´×Ô±±ÃÀÖøÃû´óѧҽҩϵµÄ˶ʿºÍ ²©Ê¿£¬ ¼ÈÓÐÀ´×ÔÖйúÌìȻҩÎïÓë·ÂÉúÒ©Îï¹ú¼ÒÖØµãʵÑéÊÒ£¬»¹Óб±ÃÀÖÆÒ©ÐÐÒµ¾Ñé·á¸»µÄ¼¼Ê¦¡£ËûÃǶÔÌìÈ»®bÆ·µÄ¹¦Ð§ºÍÒ©ÀíÌØÐÔÓÐÉîÇÐÁ˽⡣¼ÓÃÀ¿ÆÑÐÖÆÒ©ÒѲ¼À³¿Ë´óѧ£¬ POLECNECTARÂ̷佺¹«Ë¾µÈ½øÐпÆÑкÏ×÷£¬²»¶Ï¸ÄÁ¼Ñз¢²úÆ·£¬ÎñÇó¸øÓè¹Ë¿Í×î¼ÑÆ·ÖÊ¡£
6 H* W4 I" M) y8 d; S' p, g) A2 y/ ~! C
[ ±¾Ìû×îºóÓÉ ½¡¿µÓªÑøÕ¾ ÓÚ 2008-11-17 12:54 ±à¼ ]; i6 {% j' t6 y! _% D n: [
gmp.gif (9.82 KB, ÏÂÔØ´ÎÊý: 36)
4 c6 |; c5 V2 c; tGMO Approval
; C& l+ @) [/ i% h! W
: n. d, m4 Y, d5 t+ Zsite_lis.gif (14.48 KB, ÏÂÔØ´ÎÊý: 16)
8 _7 v( s6 o7 u M0 \$ rCanadian Licence$ r. G: u' b& r% j- d' _
; F3 I% J( c3 t, S- B |
|